EA202192124A1 - CD3 BINDING MOLECULES - Google Patents

CD3 BINDING MOLECULES

Info

Publication number
EA202192124A1
EA202192124A1 EA202192124A EA202192124A EA202192124A1 EA 202192124 A1 EA202192124 A1 EA 202192124A1 EA 202192124 A EA202192124 A EA 202192124A EA 202192124 A EA202192124 A EA 202192124A EA 202192124 A1 EA202192124 A1 EA 202192124A1
Authority
EA
Eurasian Patent Office
Prior art keywords
binding molecules
binding
relates
antibody
cancer
Prior art date
Application number
EA202192124A
Other languages
Russian (ru)
Inventor
Питер Фокко Ван Ло
Original Assignee
Мерус Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерус Н.В. filed Critical Мерус Н.В.
Priority claimed from PCT/NL2020/050214 external-priority patent/WO2020204708A1/en
Publication of EA202192124A1 publication Critical patent/EA202192124A1/en

Links

Abstract

Изобретение относится к вариабельным областям тяжелой цепи, связывающим доменам и антителам, специфичным к человеческим CD3 и CD3-связывающим белкам. Изобретение дополнительно относится к применению CD3-связывающего белка, предпочтительно антитела, согласно изобретению в лечении рака или аутоиммунного заболевания.The invention relates to heavy chain variable regions, binding domains and antibodies specific for human CD3 and CD3 binding proteins. The invention further relates to the use of a CD3 binding protein, preferably an antibody, according to the invention in the treatment of cancer or an autoimmune disease.

EA202192124A 2019-10-01 2020-03-27 CD3 BINDING MOLECULES EA202192124A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19200931 2019-10-01
PCT/NL2020/050214 WO2020204708A1 (en) 2019-03-29 2020-03-27 Cd3 binding molecules

Publications (1)

Publication Number Publication Date
EA202192124A1 true EA202192124A1 (en) 2022-03-15

Family

ID=68109267

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192124A EA202192124A1 (en) 2019-10-01 2020-03-27 CD3 BINDING MOLECULES

Country Status (1)

Country Link
EA (1) EA202192124A1 (en)

Similar Documents

Publication Publication Date Title
EA202092933A1 (en) ANTIBODIES TO ENTPD2, TYPES OF COMBINATION THERAPY AND METHODS OF APPLICATION OF ANTIBODIES AND TYPES OF COMBINATION THERAPY
EA201891165A1 (en) MOLECULES BINDING PD1 AND / OR LAG3
EA201891166A1 (en) CTLA4-CONNECTING SUBSTANCES
MD3328888T2 (en) Anti-psma antibodies, bispecific antigen-binding molecules that bind psma and cd3, and uses thereof
EA201990781A9 (en) ANTI-STEAP2 ANTIBODIES, CONJUGATES ANTIBODY MEDICINES AND BISSPECIFIC ANTIGEN BINDING MOLECULES THAT BIND STEAP2 AND CD3, AND THEIR APPLICATION
MX2021010877A (en) Cd3 binding molecules.
EA201691858A1 (en) ANTIBODY COMPOSITIONS FOR TREATMENT OF TUMORS
PH12021550802A1 (en) Pd-1 targeted il-15/il-15ralpha fc fusion proteins and uses in combination therapies thereof
EA201791666A1 (en) CD3 ANTIBODIES, CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES THAT SPECIFICALLY CONNECT WITH CD3 AND / OR CD123
BR112019024654A2 (en) binding protein nkg2d, cd16 and ror1 or ror2
EA201290570A1 (en) CONSTRUCTIONS CONNECTING WITH RON AND METHODS OF THEIR USE
PE20150023A1 (en) ST2 ANTIGEN BINDING PROTEINS
EA202092825A1 (en) ANTI-SIRPA ANTIBODIES AND METHODS OF THEIR APPLICATION
EA201070888A1 (en) ANTIBODIES AND THEIR DERIVATIVES
EA200701211A1 (en) POLYPEPTIDES THAT ARE BINDING WITH BR3, AND THEIR APPLICATION
EA200801621A1 (en) ANTIBODIES DIRECTED ON HER-3 AND THEIR APPLICATION
EA202192090A1 (en) ANTIGEN BINDING PROTEINS AGAINST IL2 RECEPTOR GAMMA CHAIN
EA201890928A1 (en) ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
EA202090718A1 (en) PROTEINS BINDING NKG2D, CD16 AND LECTIN-LIKE C-TYPE MOLECULE-1 (CLL-1)
NZ594682A (en) Fully human antibodies specific to cadm1
EA202190138A1 (en) ANTI-SIRP-BETA1 ANTIBODIES AND METHODS OF THEIR USE
EA202091888A1 (en) VARIABLE ANTIBODY DOMAINS TARGETED ON THE NKG2D RECEPTOR
MX2021015212A (en) Anti-sortilin antibodies for use in therapy.
EA202091569A1 (en) MONOCLONAL ANTIBODIES AND METHODS OF THEIR APPLICATION
CL2023001064A1 (en) Anti-steap1 antigen binding protein